EQNR Rises 2.8% After UBS Raises Equinor Target to NOK 380, Keeps Neutral

At 4:07:56 a.m. ET on July 23, 2026, a report that UBS had raised Equinor's price target to NOK 380 from NOK 340 was followed by EQNR jumping from 39.77 to 40.87 within one minute. The stock remained at 40.87 after 10 minutes and edged up to 40.94 by 15 minutes, extending the measured gain from 2.766% to 2.942%.

UBS raised the target but kept its Neutral rating

Reporting published on July 23, 2026 said UBS lifted its Equinor target to NOK 380 from NOK 340 while reiterating Neutral. UBS's public rating and price-target table confirms the progression: it lists a NOK 340 target and Neutral rating on July 2, followed by a NOK 380 target and the same rating on July 22.

The revised target was close to the NOK 379.60 stock price recorded in the UBS table for July 22. That makes the distinction important: the bank raised its valuation reference after Equinor's recent advance, but the published record did not show an upgrade from Neutral or a target materially above the listed share price.

The first move arrived immediately and held

EQNR was 39.77 at the release timestamp and reached 40.87 one minute later, a 2.766% increase. It was still 40.87 at the 10-minute checkpoint. At 15 minutes, the stock traded at 40.94, lifting the measured gain to 2.942%. The initial jump therefore did not reverse during the available path; it held for 10 minutes and then moved slightly higher.

The target reset followed a strong quarterly update

The analyst action came one day after Equinor's July 22, 2026 second-quarter release. The company reported adjusted operating income of $11.48 billion, adjusted earnings per share of $1.33 and production growth of 3%. Equinor also maintained an expected 2026 share-buyback programme of up to $3 billion and initiated a third tranche of up to $1.125 billion.

That sequence complicates a single-catalyst explanation. The UBS target increase aligned closely with the measured EQNR jump, but it followed fresh earnings, production and capital-return disclosures already in the market. The defensible read is narrower: EQNR reacted sharply after the analyst-action headline, held the gain through 10 minutes and strengthened slightly by 15 minutes, even though UBS retained Neutral and set its target near the prior listed share price.